Susquehanna International Group’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-30,900
| Closed | -$924K | – | 13564 |
|
|
2025
Q3 | $924K | Buy |
30,900
+7,900
| +34% | +$264K | ﹤0.01% | 7542 |
|
|
2025
Q2 | $683K | Sell |
23,000
-4,700
| -17% | -$135K | ﹤0.01% | 8426 |
|
|
2025
Q1 | $846K | Buy |
27,700
+900
| +3% | +$30.3K | ﹤0.01% | 7678 |
|
|
2024
Q4 | $1.06M | Buy |
+26,800
| New | +$1.04M | ﹤0.01% | 6800 |
|
|
2019
Q4 | – | Sell |
-8,500
| Closed | -$389K | – | 10587 |
|
|
2019
Q3 | $389K | Buy |
+8,500
| New | +$370K | ﹤0.01% | 7796 |
|
|
2019
Q2 | – | Sell |
-5,700
| Closed | -$248K | – | 10806 |
|
|
2019
Q1 | $248K | Sell |
5,700
-100
| -2% | -$5.1K | ﹤0.01% | 7544 |
|
|
2018
Q4 | $274K | Buy |
5,800
+400
| +7% | +$24K | ﹤0.01% | 7167 |
|
|
2018
Q3 | $403K | Sell |
5,400
-11,100
| -67% | -$764K | ﹤0.01% | 6916 |
|
|
2018
Q2 | $911K | Buy |
16,500
+3,000
| +22% | +$139K | ﹤0.01% | 5549 |
|
|
2018
Q1 | $514K | Buy |
13,500
+5,700
| +73% | +$177K | ﹤0.01% | 6577 |
|
|
2017
Q4 | $218K | Sell |
7,800
-2,200
| -22% | -$67.2K | ﹤0.01% | 8122 |
|
|
2017
Q3 | $310K | Buy |
10,000
+1,000
| +11% | +$27.2K | ﹤0.01% | 7328 |
|
|
2017
Q2 | $253K | Sell |
9,000
-11,400
| -56% | -$275K | ﹤0.01% | 7885 |
|
|
2017
Q1 | $491K | Buy |
20,400
+11,100
| +119% | +$272K | ﹤0.01% | 6518 |
|
|
2016
Q4 | $236K | Sell |
9,300
-1,500
| -14% | -$39.4K | ﹤0.01% | 8398 |
|
|
2016
Q3 | $325K | Buy |
+10,800
| New | +$297K | ﹤0.01% | 6798 |
|
Other funds holding SRDX
Susquehanna International Group's SRDX Position: Q4 2025 in Review
Susquehanna International Group sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 24,908 shares — an estimated $745K sold.
Susquehanna International Group first reported a position in SRDX in Q1 2015 and held it in 23 quarters. The position peaked at $5.82M in Q2 2023. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Susquehanna International Group reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Susquehanna International Group sold 24,908 Surmodics shares in Q4 2025, an estimated $745K.
- Susquehanna International Group first reported a position in Surmodics in Q1 2015 and held it in 23 quarters.
- Susquehanna International Group's Surmodics position peaked at $5.82M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.